Loading…
Alembic Pharmaceuticals (APLLTD)₹1,017+0.72%Pharmaceuticals
Alembic Pharmaceuticals is compared with the 10 closest in size in Pharmaceuticals (229 companies in the industry). It has a P/E of 28.9 against a peer median of 29.8, and ROCE of 13.1% against a peer median of 16.0%, and latest-quarter sales growth of 25.6% against a peer median of 22.3%. By market cap it is #1 of 11 in this set.
As of · Peer set: 10 closest in size in Pharmaceuticals
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Alembic Pharmaceuticals | 20,041 | 28.9 | 13.1 | 13.5 | 0.25 | 1.2 | 7,321 | 671 | 25.6 | 11.5 | — |
| Granules India | 19,820 | 29.6 | 16.0 | 13.8 | 0.30 | 0.2 | 5,343 | 593 | 22.3 | 59.3 | vs APLLTD |
| Caplin Point Laboratories | 19,024 | 28.7 | 25.1 | 20.6 | 0.00 | 0.3 | 2,186 | 651 | 19.6 | 18.5 | vs APLLTD |
| Onesource Specialty Pharma | 18,607 | — | 1.0 | −1.1 | 0.26 | 0.0 | 1,423 | −74 | 37.2 | 469.8 | vs APLLTD |
| Shilpa Medicare | 18,303 | 61.6 | 10.9 | 9.4 | 0.25 | 0.1 | 1,533 | 243 | 45.1 | 114.9 | vs APLLTD |
| Alivus Life Sciences | 18,135 | 30.0 | 24.9 | 19.0 | 0.02 | 0.3 | 2,562 | 566 | 6.3 | 31.1 | vs APLLTD |
| Pfizer | 17,905 | 24.4 | 24.0 | 18.0 | 0.02 | 1.9 | 2,522 | 722 | 8.2 | 6.4 | vs APLLTD |
| Eris Lifesciences | 17,536 | 24.6 | 14.0 | 18.7 | 0.60 | 0.6 | 3,118 | 651 | 12.6 | 39.5 | vs APLLTD |
| Cohance Lifesciences | 16,992 | 159.6 | 8.1 | 7.1 | 0.10 | 0.0 | 2,275 | 150 | −23.2 | −198.0 | vs APLLTD |
| AstraZeneca Pharma India | 16,286 | 96.2 | 29.0 | 23.3 | 0.13 | 0.6 | 2,281 | 187 | 29.8 | −32.2 | vs APLLTD |
| CORONA Remedies | 15,541 | 74.9 | 33.0 | 29.5 | 0.22 | 0.4 | 1,403 | 185 | 22.3 | 15.3 | vs APLLTD |
| Peer median | 18,135 | 29.8 | 16.0 | 18.0 | 0.22 | 0.3 | 2,281 | 566 | 22.3 | 18.5 |
Listed companies closest to Alembic Pharmaceuticals in Pharmaceuticals include Granules India, Caplin Point Laboratories, Onesource Specialty Pharma, Shilpa Medicare, Alivus Life Sciences, Pfizer, Eris Lifesciences, Cohance Lifesciences.
Alembic Pharmaceuticals, with a market cap of ₹20,041 Cr (Alembic Pharmaceuticals itself).
Alembic Pharmaceuticals trades at a P/E of 28.9; the median of its peer set is 29.8. A P/E above or below the median is a description, not a judgement on value.
Alembic Pharmaceuticals' return on capital employed is 13.1%, below the peer median of 16.0%.